Phase 2 study for people with Hepatitis B

Not yet recruiting Phase 2

Sources: ClinicalTrials.gov Checked: 11 October 2026 Not medical advice

This trial at a glance

Status Not yet recruiting
Phase Phase 2
Sponsor Vaxine Pty Ltd
Registry number NCT03038802
Started 1 March 2026 Today 16 October 2026 Estimated completion 1 March 2027

Where this trial is running

Trial sites and the status recorded for each
SiteCityState or countryStatus at this site
ARASMI Adelaide SA Status not stated

voxsanity.com.au · trial sites from public registries · registry record synced 11 October 2026 · not medical advice

Who can join

Age 18 Years and over
Sex Anyone, regardless of sex
Healthy volunteers Not accepted
Enrolment target 40

The official eligibility criteria

Registry text, reproduced exactly. These are the words the trial's sponsor published on ClinicalTrials.gov. They have not been edited, shortened or rewritten, and they are written for researchers rather than for patients.

Inclusion Criteria:

* Male or female

* 18 years of age or older

* Current evidence of HBV chronic infection (with or without cirrhosis) as indicated by detection of HBsAg and/or Hepatitis B DNA (Subjects on current nucleoside therapy may have no detectable Hep B DNA)

* If child bearing age, using contraception (barrier method, IUD or oral contraception)

* Able to provide written informed consent

* Willing and able to comply with the protocol for the duration of the study.

Exclusion Criteria:

* Positive for antibody to hepatitis B core antigen (anti-HBc) IgM with negative results for the rest of the HBV markers, indicating acute infection,

* Positive for anti-delta virus, or anti-hepatitis C virus or HIV

* Childs Pugh Score for Cirrhosis Mortality of Child grade B or greater

* Liver transaminases greater than 5 times the upper limit of normal

* History of severe allergic reaction to hepatitis B vaccine.

* Pregnancy or female of child-bearing age not using effective method of contraception.

* Presence of any other organ-specific disease that in the opinion of the investigator may result in risk to the subject from involvement in the study

* Current alcohol or drug abuse that in the opinion of the investigator may result in non-compliance.

* Participation in another clinical trial with an investigational agent within 30 days preceding initiation of treatment

Dates on the record

Started 1 March 2026
Estimated completion 1 March 2027
Registry last updated 22 September 2025
Checked by Voxsanity 11 October 2026

Results, publications and the official record

Sources and dates

  • ClinicalTrials.gov – the record this page reformats
  • ClinicalTrials.gov processing date: 22 September 2025.
  • This page last checked by Voxsanity: 11 October 2026.

Voxsanity reformats data from public registries into this layout. It does not edit, interpret or add to what the registry published.

Not medical advice.

Individual trial records are refreshed on a rolling basis rather than all at once, so a record may be up to several weeks old. Each trial page and trial card shows the date its own record was last synced. Where a record has lagged, its status, sites and enrolment can differ from the current registry state in either direction, so check the registry link on the trial page before acting on them.

Letter for your doctor

A one-page summary of this trial to print or email to your GP. It carries the registry's own record of the trial and its eligibility criteria, and nothing Voxsanity has written about whether it suits you.